Pfizer's COVID vaccine looks promising, but big hurdles remain

(HealthDay)—Early COVID-19 vaccine trial results announced by Pfizer this week caused hopes to soar for a swift end to the pandemic that has killed more than 242,000 and infected more than 10 million in the United States alone.